tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

PharmaCyte Biotech Boosts Investment in TNF Pharmaceuticals

Story Highlights
  • PharmaCyte Biotech increased its investment in TNF Pharmaceuticals by $3 million.
  • The investment supports TNF’s use of LightSolver’s technology in cryptocurrency mining.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
PharmaCyte Biotech Boosts Investment in TNF Pharmaceuticals

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

PharmaCyte Biotech ( (PMCB) ) has issued an update.

On September 2, 2025, PharmaCyte Biotech, Inc. announced an increased investment of $3 million in TNF Pharmaceuticals to support TNF’s acquisition of a license with LightSolver, a company recognized for its innovative computing technology. This strategic move aims to leverage LightSolver’s technology in cryptocurrency mining and blockchain, potentially enhancing TNF’s market position and operational capabilities.

More about PharmaCyte Biotech

PharmaCyte Biotech, Inc. operates in the biotechnology industry, focusing on developing cellular therapies for cancer and diabetes. The company is well-capitalized with significant cash resources and is actively seeking to diversify its investment portfolio.

Average Trading Volume: 52,797

Technical Sentiment Signal: Sell

Current Market Cap: $6.35M

For an in-depth examination of PMCB stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1